Prevalence of and risk factors for fungal vaginitis caused by non-albicans species

American Journal of Obstetrics and Gynecology

Volumn 176, Issue 1 I, 1997, Pages 138-141

  Spinillo, Arsenio ^a,b,c   Capuzzo, Ezio ^a,b   Gulminetti, Roberte ^c   Marone, Piero ^b,c   Colonna, Laura ^a,b,c   Piazzi, Gaia ^a,b,c  

^a Istituto di Ricovero e Cura a Carattm Sdentifico Policlinico San Matteo ^*

^b Clinica Ostetrico Ginecologica

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Fungal infections; Mycotic vaginitis; Non albicans species

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROBIOLOGY; MYCOSIS; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; VAGINITIS;

ADULT; FEMALE; HIV SEROPOSITIVITY; HUMANS; MYCOSES; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VAGINITIS;

EID: 0030638632     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(97)80026-9     Document Type: Article

References (12)

1. Sobel JD. Vaginal infections in adult women. Med Clin North Am 1990;74:1573-601.
2. Horowitz BJ. Mycotic vulvovaginitis: a broad overview. Am J Obstet Gynecol 1991;165:1188-92.
3. Bingham JS. Vulvovaginal candidiasis: an overview. Acta Derm Venereol 1986;121(Suppl):39-46.
4. Sobel JD. Candidal vulvovaginitis. Clin Obstet Gynecol 1993;36:153-65.
5. Law D, Moore CB, Wardle HM, Ganguli LA, Keaney MGL, Denning DW. High prevalence of antifungal resistance in Candida spp from patients with AIDS. J Antimicrob Chemother 1994;34:659-68.
6. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, KarpJE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with flnconazole. N Engl J Med 1991;325: 1274-7.
7. Nyirjesy P, Seeney SM, Terry Grody MH, Jordan CA, Buckley HR. Chronic fungal vaginitis: the value of cultures. Am J Obstet Gynecol 1995:173:820-3.
8. Odds FC. Candida and candidosis. 2nd ed. London: Balliere Tindall, 1988.
9. Rc-dondo-Lopez V, Lynch M, Schmitt C, Cook R, Sobel JD. Torulop.fis glabrata vaginitis: clinical aspects and susceptibilities to antifungal agents. Obstet Gynecol 1990;76:651-5.
10. Spinillo A, Capuzzo E, Egbe TO, Baltaro F, Nicola S, Piazzi G. Torulopsis glabrata vaginitis. Obstet Gynecol 1995;85:993-8.
11. Johnson EM, Warnock DW, Luker J, Porter SR, Scully C. Emergence of azole drug resistance in Candida species from HFV'-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother 1995;35: 103-14.
12. Denning DW. Can we prevent azole resistance in fungi? Lancet 1995;346:454-5.